PMID- 15902366 OWN - NLM STAT- MEDLINE DCOM- 20090326 LR - 20050519 IS - 1615-6692 (Electronic) IS - 0340-9937 (Linking) VI - 30 IP - 3 DP - 2005 May TI - [The coagulation cascade--clinical implications]. PG - 170-5 AB - The coagulation system is a cascade of complex, interacting steps, that can selectively be inhibited in distinct ways. Thus, various therapeutic options are offered, concerning primary hemostasis, which results in formation of a platelet-rich thrombus, as well as secondary hemostasis, resulting in fibrin formation. For patients with coronary artery disease, who have to undergo percutaneous coronary intervention (PCI), a sufficient anticoagulant strategy is essential for prevention of ischemic events, due to the activated state of the coagulation system of these patients. Next to antiplatelet therapy, unfractionated heparin (UFH) is a well-established concomitant intravenous therapy during PCI. Also low-molecular-weight heparins (LMWH) are increasingly used in this setting due to their favorable pharmacodynamic properties. The exact value of these substances in comparison to UFH is not completely evaluated yet. FAU - Langer, Harald AU - Langer H AD - Medizinische Klinik und Poliklinik, Abteilung III, Universitatsklinikum Tubingen, Eberhard-Karls-Universitat Tubingen, Tubingen. FAU - Gawaz, Meinrad AU - Gawaz M LA - ger PT - English Abstract PT - Journal Article PT - Review TT - Die Gerinnungskaskade-Mechanismen und klinische Implikationen. PL - Germany TA - Herz JT - Herz JID - 7801231 RN - 0 (Anticoagulants) RN - 0 (Platelet Aggregation Inhibitors) RN - 9001-31-4 (Fibrin) SB - IM MH - Anticoagulants/*administration & dosage MH - Blood Coagulation/*drug effects MH - Fibrin/*metabolism MH - Humans MH - Platelet Aggregation Inhibitors/*administration & dosage MH - Thrombosis/*physiopathology/*prevention & control RF - 40 EDAT- 2005/05/20 09:00 MHDA- 2009/03/27 09:00 CRDT- 2005/05/20 09:00 PHST- 2005/05/20 09:00 [pubmed] PHST- 2009/03/27 09:00 [medline] PHST- 2005/05/20 09:00 [entrez] AID - 10.1007/s00059-005-2691-8 [doi] PST - ppublish SO - Herz. 2005 May;30(3):170-5. doi: 10.1007/s00059-005-2691-8.